Filing Details
- Accession Number:
- 0001209191-22-057939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-18 17:16:17
- Reporting Period:
- 2022-09-27
- Accepted Time:
- 2022-11-18 17:16:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-09-27 | 105 | $2.57 | 197,180 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-28 | 105 | $2.52 | 197,285 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-29 | 105 | $2.51 | 197,390 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-30 | 105 | $2.61 | 197,495 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-03 | 105 | $2.54 | 197,600 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-04 | 105 | $2.61 | 197,705 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-05 | 105 | $2.58 | 197,810 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-06 | 105 | $2.65 | 197,915 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-07 | 105 | $2.66 | 198,020 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-10 | 105 | $2.53 | 198,125 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-11 | 105 | $2.48 | 198,230 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-12 | 105 | $2.49 | 198,335 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-13 | 105 | $2.38 | 198,440 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-14 | 105 | $2.31 | 198,545 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-17 | 105 | $2.33 | 198,650 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-18 | 105 | $2.46 | 198,755 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-19 | 105 | $2.42 | 198,860 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-20 | 105 | $2.44 | 198,965 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-21 | 105 | $2.49 | 199,070 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-24 | 105 | $2.38 | 199,175 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-25 | 105 | $2.44 | 199,280 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-26 | 105 | $2.42 | 199,385 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-27 | 105 | $2.49 | 199,490 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-28 | 105 | $2.52 | 199,595 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-31 | 105 | $2.54 | 199,700 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.